Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients…
– Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc.…
Second major acquisition sets Singapore headquartered company on course to uniquely drive global therapeutic innovation from Asia SINGAPORE–(BUSINESS WIRE)–AUM Biosciences…
Novartis said Tuesday that the USFDA marked its investigational sickle cell drug crizanlizumab for Priority Review, which could be the first monoclonal antibody targeting the P-selectin mediated multi-cellular adhesion in sickle cell disease.
Arbutus Biopharma’s AB-506 is a potent oral capsid inhibitor, preliminary results from testing have shown, the company said Monday.
Continued growth in 2019 marked by new HD-X product launch, acquisition of the leading neurofilament light (Nf-L) antibody supplier, new…
City of Hope’s Arthur D. Riggs, Ph.D., a world-renowned expert in molecular biology and diabetes, and his wife, Jane, established…
ALACHUA, Fla.–(BUSINESS WIRE)–CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease…
Microphyt secures one of the largest fundraising in the microalgae sector; The round was co-led by Sofinnova Partners and Bpifrance…
Gerresheimer AG has had a successful second quarter, en route to meeting all of its targets for 2019, Dietmar Siemssen, the CEO, has said in a press release Tursday.